Interstitial Cystitis Association
Cafe ICA

Free online
monthly news digest


JOIN OUR MAILING LIST

Bladder Instillations

Some people benefit from bladder instillations or bladder cocktails, which are mixtures of medicines put directly into the bladder. Types of instillations include:

DMSO
Dimethyl sulfoxide (DMSO, brand name RIMSO-50) was the first and remains the only FDA-approved bladder instillation specifically for interstitial cystitis (IC). Approved in 1978, its exact mechanism of action is still not fully known, though it is thought to have several effects positive effects:

  • Reducing bladder irritation and pain (anti-inflammatory)
  • Helping to relax the bladder and pelvic muscles (antispasmodic)
  • Relieving pain by depleting the level of substance P levels from bladder nerves
  • Increasing bladder capacity by breaking down scar tissue by preventing the formation of collagen, a protein the body uses to create scar tissue

Because of its ability to penetrate the bladder lining, some healthcare providers add DMSO to “bladder cocktails” to aid the absorption of other bladder-instilled medicines, such as heparin, steroids, bicarbonate, and analgesics (pain medicines).

Dosage & Treatment Plan
Typically, your healthcare provider instills a 50% liquid solution of DMSO intravesically, meaning via a catheter directly into your bladder.You then hold the solution in your bladder for up to 15 minutes before urinating it out.  Though usually done in your healthcare provider’s office, you can learn you do DMSO instillations at home. You may find your urologist’s nurse practitioner to be very helpful in teaching you this technique.

You will receive a series of instillations, generally every one or two weeks for four to eight weeks, depending on your response to the medicine. You may not see improvement in your symptoms until the third or fourth treatment. If you experience a recurrence in your symptoms, additional treatments may be necessary. Some people with IC find that, once they have had the initial series of instillations, they need only one DMSO instillation when an IC flare occurs. It is best to schedule a treatment as soon as your symptoms begin to recur, rather than waiting until symptoms have intensified.

Wait three to four weeks after a cystoscopy with hydrodistention to start DMSO instillation. This ensures that the bladder has a chance to begin to heal, including any biopsy sites (small areas of tissue samples your doctor may cut from your bladder during cystoscopy with hydrodistention, to help aid in diagnosis). Also, prior to starting DMSO therapy, your healthcare provider orders a urine culture test and, before each instillation, a urinalysis to ensure that you do not have a urinary tract infection.

Potential Side Effects
A strong garlic-like taste or smell may be present on your breath and skin for 24 hours after DMSO instillation. You may not notice this odor, though anyone in close proximity to you may detect it. You may also experience a temporary worsening of bladder symptoms lasting 24 to 72 hours after treatment. Anecdotally, some patients report short-lived flu-like symptoms after DMSO treatment.

You may find that you experience pain during or after the DMSO instillation procedure, which may subside with repeated instillations. If you experience pain:

  • Ask your physician to prescribe pain medicines such as anticholinergics, bladder analgesics, or B&O suppositories, that you can use prior to and after instillation.
  • Request a pediatric catheter for the instillation.
  • Apply a numbing gel such as lidocaine to the urethra prior to catheter insertion.
  • Ask your doctor about inserting a numbing agent such as lidocaine or bupivacaine hydrochloride (Marcaine) into the bladder before DMSO instillation.

Other Precautions
In use since the 1970s, DMSO is a safe and effective IC treatment option through patient-reporting and several small-scale studies. However, because of the strong garlic odor that DMSO produces, large-scale placebo-controlled studies in humans are limited. In much higher doses than used to treat IC, DMSO can be teratogenic, meaning that it has the potential to cause birth defects. Therefore, the manufacturer of the product does not recommend its use during pregnancy or when breastfeeding.Because of the potential for cataract formation in animal studies, the manufacturer’s literature recommends that you have full eye examinations prior to and during treatment with DMSO.  No studies evaluated the safety and effectiveness of DMSO instillations in children. [Please see manufacturer’s literature for complete details].

To get more information on RIMSO-50, including complete prescribing information, call 888-258-4199 or visit http://www.bionichepharmausa.com/.

Sodium Hyaluronate
To treat IC, sodium hyaluronate solution (Cystistat) is instilled directly into the bladder. Cystistat is not yet approved for use in the United States. However, it is approved for IC treatment in the European Union and Canada as a temporary replacement for a defective mucosal lining of the bladder, which many researchers believe is responsible for causing IC symptoms.

Clinical trials tested the effectiveness of sodium hyaluronate solution, also called hyaluronic acid, in treating IC. As a result, Cystistat is prescribed in more than 20 countries, including the United Kingdom, Canada, Austria, France, Germany, Greece, Ireland, Italy, Netherlands, Portugal, Scandinavia, Spain, Switzerland, China, and others.

Dosage & Treatment Plan
Cystistat is usually instilled once a week for 4 to 6 weeks and then monthly thereafter. One treatment is given every one or two weeks for four to eight treatments, depending on the patient’s response to the medicine. Many patients begin to experience relief after the fifth or sixth instillation. Some patients who respond positively may be able to increase the interval between treatments once the symptoms have stabilized.

Potential Side Effects
Side effects are reported to be minimal, limited primarily to minor discomfort due to catheterization, resulting in initial exacerbation of urinary frequency and urgency.

Pregnancy & Children
Because adequate and well controlled studies have not been performed in pregnant women, the manufacturer does not recommend its use during pregnancy. The safety and effectiveness of Cystistat use in children has not been established.

You or your healthcare provider can obtain more information about Cystistat from Bioniche Pharma by emailing info@cystistat.com.

Heparin
Heparin is a compound that has both anti-inflammatory and surface protective actions. Heparin can mimic the activity of the bladder’s mucous lining, temporarily “repairing” the GAG layer, which may be defective in IC.

Clinical studies on the effectiveness of heparin are limited. In one uncontrolled investigation, intravesical heparin resulted in some improvement of symptoms in about 50 percent of patients. Another study of patients undergoing DMSO treatments indicated that heparin might help reduce their relapse rate. Patients treated with DMSO alone had a relapse rate of 52 percent, while those maintained with monthly instillations of heparin and followed for 12 months had a relapse rate of 20 percent.

Dosage & Treatment Plan
While this drug can be given either by injection or by bladder instillation, the method of choice for the treatment of IC is bladder instillation. It can be used as a primary treatment method, as a component of an instilled “bladder cocktail” or as a “maintenance medicine” to supplement other types of treatment. Heparin is also combined with alkalinized lidocaine to form a “rescue remedy” for use during IC flares.

A heparin solution of 10,000 units diluted with saline solution is instilled intravesically daily, and held in the bladder for 20 to 30 minutes. Patients can be taught to self-catheterize and administer the treatments at home. After 3 to 4 months the frequency of instillations is reduced to 3 to 4 times per week.

It takes 3 to 6 months to begin to see improvement, but therapy should continue for at least 12 months. If there is no improvement in symptoms after 3 months, the dosage is increased to 20,000 units. Therapy can be continued indefinitely.

Potential Side Effects
The side effects of bladder instillation of heparin are limited primarily to pain, irritation, or discomfort resulting from frequent catheterization.

Bladder Cocktails
Below are some ICA Medical Advisory Board members’ bladder cocktail recipes. Many patients may be able to do instillations of these cocktails at home, after in-office education. If a solution causes your patient dysuria, it can be drained by catheter. In that case, in-office administration is more practical.

Kristene Whitmore, MD—Drexel University College of Medicine
Whitmore Cocktail

  • 0.5% bupivacaine (Marcaine, 20 mL) 
  • 10,000 IU heparin (10 mL)
  • 100 mg hydrocortisone (5 mL of normal saline)
  • 40 mL sodium bicarbonate 48 mmol
Try using with patients who self-administer at home. For patients who have had a documented UTI within three months of the instillation, add 80 mg gentamicin (5 mL of normal saline) to this mixture. Usually, give six weekly instillations. For patients who have premenstrual flares, try giving monthly instillations during the flare.

Robert Moldwin, MD—Smith Institute for Urology & Long Island Jewish Medical Center
Anesthetic/Steroid cocktail
  • 1:1 mixture of 0.5% bupivacaine (Marcaine) and 2% lidocaine jelly (about 30 to 40 mL total)
  • 40 mg triamcinolone (usually use 80 mg for Hunner's ulcer patients)
  • 10-20,000 IU heparin
  • 80 mg gentamicin
Perform this instillation weekly in the office, or up to three times a week by patients at home. Longer-lasting improvement in symptoms may take up to 12 weeks. Once symptoms have improved, increase the time between instillations. In instances where patients describe loss of cocktail efficacy, we usually switch to "DMSO cocktail" and may come back to the anesthetic cocktail at a later date, if needed.

Alkalinized lidocaine cocktail
  • 25 mL 2% lidocaine
  • 5 mL sodium bicarbonate
  • 10,000 IU heparin
  • 80 mg gentamicin
In studies with alkalinized lidocaine, bicarbonate was instilled after lidocaine, but mixing this solution and instilling it “fresh” should avoid problems with precipitation.

DMSO cocktail
  • 50 mL Rimso-50 (DMSO)
  • 10-20,000 IU heparin
  • 40 mg triamcinolone
  • 10 mL sodium bicarbonate
  • 80 mg gentamicin
Christopher Payne, MD—Stanford University
Payne Cocktail I
  • 10,000 IU of heparin
  • 10 mL of bupivacaine (Marcaine)
Usually prescribe for self-instillation daily or three times a week. Sometimes, use this cocktail as a weekly office treatment.

Payne Cocktail II
  • 50 mL of Rimso-50 (DMSO)
  • 100 mg hydrocortisone (Solu-Cortef) plus 10 mL bupivacaine (Marcaine)
  • 5 mL sodium bicarbonate
  • Heparin (may add heparin; however, heparin is usually reserved as a separate treatment)
Instill 30 to 50 mL of the above into the bladder and ask the patient to try to hold the solution for 30 minutes. Belladonna and opium (B & O Supprettes) rectal suppositories may be used to help hold the cocktail in the bladder for longer periods. Perform instillations each week for six to eight weeks. If there is improvement, decrease the time between instillations to two weeks, three weeks, one month, and then discontinue.

New Instillations Under Development
New approaches to instillation therapy for IC are being tried and tested, with a focus on longer-term results or even healing rather than “rescue.” These include:

  • PSD597 (Plethora Solutions)
    This is the formulation of alkalinized lidocaine used in the clinical trial published earlier this year. It includes a delivery system and a proprietary formulation said to protect the active drug in the bladder and ensure that the drug remains in the optimal chemical form for transport across the bladder wall to its site of action.
  • URG101 (Urigen)
    This is a formulation of alkalinized lidocaine and heparin for instillation. Interim analysis of a phase 2 trial showed significant improvement in average daytime pain, daytime urgency, and symptom score.
  • Uracyst (Stellar Pharmaceuticals)
    This formulation of sterile sodium chondroitin sulfate solution (2.0%) is approved for marketing in Canada and Europe. It is thought to replace the damaged glycosaminoglycan layer of the bladder. In an uncontrolled, six-week Canadian trial in 53 patients with moderately severe IC received weekly instillations for six weeks, then monthly over 16 weeks for a total of 10 treatments. At 10 and 24 weeks, symptom and bother scores were significantly reduced.
  • Liposomes for instillation (Lipella)
    The first human trial of liposomes for instillation was published online in August 2009 (Chuang YC et al. J Urol. 2009;182:1393-1400). In this small trial, liposomes instilled once a week for four weeks were compared with oral pentosan polysulfate (Elmiron) 100 mg three times a day for four weeks. Both reduced frequency and nocturia significantly, but patients who received liposomes also had significant decreases in pain, urgency, and O’Leary-Sant symptom scores.
  • Misoprostol (Cytotec) for instillation
    This prostaglandin E1 analog is used orally to reduce the risk of NSAID-induced gastric ulcers. NSAIDs interfere with the NF-kappa B signaling pathway prevent production of prostaglandins. Because this pathway is damaged in IC cells, Raymond Rackley, MD, at the Cleveland Clinic, theorized that this drug may help heal IC bladder lining. It is being used experimentally only in patients with severe IC for whom treatments short of surgery have failed.
  • GABA IC (Clinical Apothecaries Compounding Pharmacy)
    Formulated by a compounding pharmacist working with local urologists and urogynecologists, the instillation cocktail contains an antihistamine, a steroidal anti-inflammatory agent, an anticonvulsant, and an amino acid precursor of nitric oxide.



Revised September 15, 2009